Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
about
Posttranslational Modifications and the Immunogenicity of BiotherapeuticsMitochondrion: A Promising Target for Nanoparticle-Based Vaccine Delivery Systems.Outer membrane vesicles as platform vaccine technologySelf-assembling protein nanoparticles in the design of vaccinesThe Two-Faced Potato Virus X: From Plant Pathogen to Smart NanoparticleThe Use of Synthetic Carriers in Malaria Vaccine DesignSynthetic self-adjuvanting glycopeptide cancer vaccinesModes of Antigen Presentation by Lymph Node Stromal Cells and Their Immunological ImplicationsChoice and Design of Adjuvants for Parenteral and Mucosal VaccinesVirus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemicFilamentous bacteriophage fd as an antigen delivery system in vaccinationStrategy for Designing a Synthetic Tumor Vaccine: Multi-Component, Multivalency and Antigen ModificationMessenger RNA-based vaccines: progress, challenges, applicationsEarly IFN-gamma production after YF 17D vaccine virus immunization in mice and its association with adaptive immune responsesPrecisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody ResponsesRational HIV Immunogen Design to Target Specific Germline B Cell ReceptorsSynthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial VirusHigh-Density Lipoproteins: Nature's Multifunctional NanoparticlesSynthetic Nanoparticles for Vaccines and ImmunotherapyEngineering New Approaches to Cancer VaccinesProgrammable polyproteams built using twin peptide supergluesCarbon nanotubes' surface chemistry determines their potency as vaccine nanocarriers in vitro and in vivoInteractions of nanomaterials and biological systems: Implications to personalized nanomedicinePeripherally administered nanoparticles target monocytic myeloid cells, secondary lymphoid organs and tumors in miceA Modular Vaccine Development Platform Based on Sortase-Mediated Site-Specific Tagging of Antigens onto Virus-Like ParticlesExploiting virus-like particles as innovative vaccines against emerging viral infectionsThe S. aureus 4-oxalocrotonate tautomerase SAR1376 enhances immune responses when fused to several antigens.Max Bergmann lecture protein epitope mimetics in the age of structural vaccinologyFrom Immunologically Archaic to Neoteric Glycovaccines.An update on safety and immunogenicity of vaccines containing emulsion-based adjuvants.Enhanced neutralizing antibody titers and Th1 polarization from a novel Escherichia coli derived pandemic influenza vaccine.Safety and immunogenicity of influenza whole inactivated virus vaccines: A phase I randomized clinical trial.Induction of systemic and mucosal immunity against methicillin-resistant Staphylococcus aureus infection by a novel nanoemulsion adjuvant vaccine.Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.Progress in molecular imaging in endoscopy and endomicroscopy for cancer imaging.Enhancement of MHC-I antigen presentation via architectural control of pH-responsive, endosomolytic polymer nanoparticles.Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA Trials.Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody responseAntigen vehiculization particles based on the Z protein of Junin virus.
P2860
Q26748614-6E46DBB1-2926-4DB9-9D8A-E1D34E4A6F02Q26748776-BBD3B19B-00D7-4EF2-B156-CBD717BE4CDEQ26766539-41FE4689-5FEB-4C33-B3E0-B100EFBB00C0Q26767097-67CCA857-F59C-43F2-800F-EB09C70CF893Q26774624-838AF97A-AA29-4516-BA9E-DEF02D445B44Q26777053-327BB404-0649-4186-9DF2-349263155592Q26777837-13D768CE-3D36-4471-B97D-695A480106CDQ26781338-6CA67503-A764-4300-8ACD-B0B4BE2717BCQ26783488-5B8A24ED-BD95-4DB1-9B84-9B6316C3A6E4Q26860373-6D6CCFDE-4B9E-4AB5-A8D0-A631911AA708Q26864071-1CF31EA9-2BA2-4519-9AF7-551C0DA2CCFEQ27001592-EB31E6F0-2905-425E-B434-9ED1FB1C3296Q27012738-6787CBB6-7DAF-4152-BB36-548690BCFE17Q27300788-7AC13871-42DB-4D9E-AD25-3705F233F5E2Q27493140-469D93AA-0518-45E8-9C26-A5D4922581F9Q27677104-4952F120-C7BD-409B-A48A-C8EF7768A7AAQ28067143-1E182065-603B-4511-B777-32D8898B0775Q28077290-A10D29DB-3243-4797-99A4-CE9F37214AA6Q28085375-0FCEA391-63ED-40DB-96F1-E5703C178C0DQ28085563-B975CF0A-6182-4368-8CBE-FB9EADB5870DQ28272295-4A0AE3D2-E56E-429E-9DF3-967110828D93Q28388765-87FD2B26-38BC-45F7-8466-B71CABDADBFDQ28391849-A044CB59-2C8D-4EF1-A184-8E1F685F1A24Q28486624-AE8AFF83-C7FD-403F-A06B-305DF1E2D4F0Q28834387-914408ED-AE13-4542-998C-AC943FB8707EQ29365799-DF969F74-F9B7-4E8D-8873-6597681C80DBQ29994694-ADE4B5FD-0A8D-4D36-889E-6CA2DE3B510AQ30155145-BFDEFFAA-4677-4E0F-9D14-E6A998517ACDQ30238724-75C61C33-3CEC-4660-96FF-19ADFA6CCFE3Q30352329-E759C5C2-E524-4B4E-A7C7-5D76A59B80EEQ30355360-7DC38359-64D0-44F2-83BC-E71C238DE979Q30372521-AC9A0079-13FB-4988-8A50-F2C1D1CB2B33Q30382453-D06CD4AF-03EC-447D-A6F1-000316763612Q30395028-A27C3EED-8161-4198-B2AF-957F71298932Q30421007-85FBDCC5-363E-4A9B-BAB7-CFB8F7418EB9Q30426514-7DD32357-4EC8-4290-980D-04633A018A7CQ30877907-A2379245-DD30-410F-ACE0-BEB49ABC7EF9Q30970916-29770417-5E0F-4358-97CD-9F00723F6721Q31036522-ACD8D469-23B7-43E8-90E7-95B5853DE501Q31106232-5372F229-EE11-49A5-B8C5-5A7ECF309828
P2860
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 October 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
@en
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
@nl
type
label
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
@en
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
@nl
prefLabel
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
@en
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
@nl
P356
P1476
Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns.
@en
P2093
Gary T Jennings
Martin F Bachmann
P2888
P304
P356
10.1038/NRI2868
P577
2010-10-15T00:00:00Z
P5875
P6179
1047690272